Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver FitzGerald

Showing results (101-110 of 288) with videos related to

Pageof 29
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Modulation of orphan nuclear receptor NURR1 expression by methotrexate in human inflammatory joint disease involves adenosine A2A receptor-mediated responsesJennifer A Ralph, Alice N McEvoy, David Kane, et al.
The American Journal of Pathology|February 27, 2007
A role for type 1alpha corticotropin-releasing hormone receptors in mediating local changes in chronically inflamed tissueJennifer A Ralph, Davide Zocco, Barry Bresnihan, et al.
Arthritis and Rheumatism|October 19, 2011
HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotypeRobert Winchester, Gregory Minevich, Valeria Steshenko, et al.
Rheumatology (Oxford, England)|February 7, 2016
Striking difference of periarticular bone density change in early psoriatic arthritis and rheumatoid arthritis following anti-rheumatic treatment as measured by digital X-ray radiogrammetryAgnes Szentpetery, Eric Heffernan, Muhammad Haroon, et al.
BMC Musculoskeletal Disorders|January 15, 2011
Randomised controlled trial examining the effect of exercise in people with rheumatoid arthritis taking anti-TNFα therapy medicationAngela Reid, Audrey Brady, Catherine Blake, et al.
Clinical Rheumatology|September 12, 2021
Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trialsAlan J Kivitz, Oliver FitzGerald, Peter Nash, et al.
The Lancet. Rheumatology|January 26, 2026
The path to interception in psoriatic disease: from conceptual clarity to clinical translationDylan McGagh, Ashley Elliott, Teresa Grohmann, et al.
Musculoskeletal Care|June 22, 2018
Advanced musculoskeletal physiotherapy practice in Ireland: A National SurveyOrna Fennelly, Catherine Blake, Oliver FitzGerald, et al.
The Journal of Rheumatology|May 18, 2010
Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritisAnne-Marie Tobin, Douglas J Veale, Oliver Fitzgerald, et al.
Annals of the Rheumatic Diseases|October 13, 2011
Application of composite disease activity scores in psoriatic arthritis to the PRESTA data setOliver FitzGerald, Philip Helliwell, Philip Mease, et al.
Pageof 29

Showing results (101-110 of 288) with videos related to

Sort By:
Pageof 29
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Modulation of orphan nuclear receptor NURR1 expression by methotrexate in human inflammatory joint disease involves adenosine A2A receptor-mediated responsesJennifer A Ralph, Alice N McEvoy, David Kane, et al.
The American Journal of Pathology|February 27, 2007
A role for type 1alpha corticotropin-releasing hormone receptors in mediating local changes in chronically inflamed tissueJennifer A Ralph, Davide Zocco, Barry Bresnihan, et al.
Arthritis and Rheumatism|October 19, 2011
HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotypeRobert Winchester, Gregory Minevich, Valeria Steshenko, et al.
Rheumatology (Oxford, England)|February 7, 2016
Striking difference of periarticular bone density change in early psoriatic arthritis and rheumatoid arthritis following anti-rheumatic treatment as measured by digital X-ray radiogrammetryAgnes Szentpetery, Eric Heffernan, Muhammad Haroon, et al.
BMC Musculoskeletal Disorders|January 15, 2011
Randomised controlled trial examining the effect of exercise in people with rheumatoid arthritis taking anti-TNFα therapy medicationAngela Reid, Audrey Brady, Catherine Blake, et al.
Clinical Rheumatology|September 12, 2021
Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trialsAlan J Kivitz, Oliver FitzGerald, Peter Nash, et al.
The Lancet. Rheumatology|January 26, 2026
The path to interception in psoriatic disease: from conceptual clarity to clinical translationDylan McGagh, Ashley Elliott, Teresa Grohmann, et al.
Musculoskeletal Care|June 22, 2018
Advanced musculoskeletal physiotherapy practice in Ireland: A National SurveyOrna Fennelly, Catherine Blake, Oliver FitzGerald, et al.
The Journal of Rheumatology|May 18, 2010
Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritisAnne-Marie Tobin, Douglas J Veale, Oliver Fitzgerald, et al.
Annals of the Rheumatic Diseases|October 13, 2011
Application of composite disease activity scores in psoriatic arthritis to the PRESTA data setOliver FitzGerald, Philip Helliwell, Philip Mease, et al.
Pageof 29